From [email protected] Tue Mar  7 16:37:05 1995
Path: uunet!bounce-back
From: Linda Palund 
Newsgroups: news.announce.newgroups,news.groups,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,sci.med,sci.med.immunology
Subject: RFD: misc.health.lyme-disease
Followup-To: news.groups
Date: 7 Mar 1995 15:34:58 -0500
Organization: monkeypa.demon.co.uk
Lines: 112
Sender: [email protected]
Approved: [email protected]
Message-ID: <[email protected]>
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:6345 news.groups:137985 alt.med.fibromyalgia:15690 alt.support.arthritis:3185 misc.health.arthritis:880 sci.med:119451 sci.med.immunology:1090

                        REQUEST FOR DISCUSSION

PROPOSED GROUP:

misc.health.lyme-disease        Lyme Disease and related issues.
                                Unmoderated.


This is a formal Request For Discussion concerning the creation of an
unmoderated newsgroup to be called misc.health.lyme-disease.  This RFD
is being posted in accordance with the Guidelines for Newgroup
Creation.  Its language is based on previously submitted RFDs.  Its
format follows a suggestion by David C. Lawrence, the moderator of
news.announce.newgroups.


RATIONALE:

There is currently no discussion group for the many persons suffering
>from Lyme Disease, a devastating illness which is prevalent all over
the world, between the same latitudes and wherever the disease
carrying tick thrives.  This disease has become a problem from North
America to Slovakia and beyond, with symptoms as varied as the
terrain. Patients are often left isolated by their debilitating
symptoms in quite rural locations.

Because their activities often take them into areas where the tick is
found, Lyme Disease is particularly common among teenagers and young
children.  Fortunately, many of these young people have access to a
computer, usually through their school. Both young patients and adult
sufferers may never actually meet another Lyme Disease patient face
to face, and being able to communicate via a Lyme Disease newsgroup
could be invaluable help in easing their fears and giving them the
support they need, for although there are Lyme Disease support groups
in various geographic locations, the severe limitations of the varied
symptoms experienced by patients make it often impossible for them to
physically attend these groups. This proposed newsgroup would give
housebound patients a much needed forum to discuss their
problems,symptoms, fears and victories.


MAILING LISTS:

There currently exists a Lyme Disease Mailing List, LymeNet, which
publishes an informational newsletter to its 1200 direct subscribers,
as well as being gated to the sci.med newsgroup.  In addition, I am
aware that many people copy the LymeNet Newsletter and redistribute
it as per the reprint agreement.

LymeNet is useful for the dissemination of new information about Lyme
disease as it is made available and will definitely be useful as a
resource for the proposed discussion group, but it is not able to
offer the give and take that an open discussion group can offer and
the publishers of LymeNet have no plans to make such a discussion
group available to all sites.  I am planning to ask the publishers to
gateway the LymeNet Mailing List to misc.health.lyme-disease.


CHARTER:

The proposed newsgroup would be intended for discussion about the many
different aspects of Lyme Disease as experienced by patients, their
caregivers, friends and family members, doctors and other medical
professionals, or anyone affected by or involved with Lyme Disease.

Anyone with an interest in Lyme Disease is free to post, including the
medical and scientific community, but this newsgroup is mainly
interested in fostering communication between Lyme Disease sufferers
>from all parts of the globe, rather than purely medical or scientific
debate, although these discussions will be welcome for informational
purposes.

The following are examples of possible posting topics:

- symptoms and questions arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community confronting Lyme Disease
- new information and resources available about this illness
- related practical problems and solutions

Commercial advertisements may NOT be posted to this proposed group.


PROCEDURE:

After a discussion period of 21-30 days, and if there are no
overwhelming objections to the proposed group, there will be a Call
For Votes (CFV) posted to the same groups as this RFD.  The voting
period will be at least 21 days.  If the group passes by receiving
a 2/3rds majority of YES votes to all valid YES & NO votes as well as
100 more YES votes than NO votes, it will be created.


DISTRIBUTION:

This RFD is being posted to the following relevant newsgroups:

  news.announce.newgroups, news.groups
  alt.med.fibromyalgia, alt.support.arthritis, misc.health.arthritis
  sci.med, sci.med.immunology

Subsequent discussion should take place in news.groups, or by
private e-mail to the proponent.  The headers of this message are
set to direct standard Usenet software to do this automatically.
Please send a copy of every followup article to the proponent as
well to avoid being accidentally ignored.


Proposed by:    Linda Palund     
Mentor:         Taneli Huuskonen 

From [email protected] Thu May 25 18:47:02 1995
Path: uunet!bounce-back
From: Linda Palund 
Newsgroups: news.announce.newgroups,news.groups,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,sci.med,sci.med.immunology
Subject: 2nd RFD: sci.med.diseases.lyme
Date: 23 May 1995 15:33:44 -0400
Organization: Monkeypaw Productions
Lines: 133
Sender: [email protected]
Approved: [email protected]
Message-ID: <[email protected]>
NNTP-Posting-Host: rodan.uu.net
Folloup-To: news.groups
Xref: gs2.UU.NET news.announce.newgroups:6874 news.groups:150933 alt.med.fibromyalgia:23106 alt.support.arthritis:4144 misc.health.arthritis:1641 sci.med:128965 sci.med.immunology:1650

                     REQUEST FOR DISCUSSION (RFD)
               unmoderated group sci.med.diseases.lyme

   changed proposal from unmoderated group misc.health.lyme-disease

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease and related issues.


This is a formal Request For Discussion concerning the creation of an
unmoderated newsgroup to be called sci.med.diseases.lyme.

This is the same group that was recently proposed under the title of
misc.health.lyme-disease.  After a long discussion period it was
decided by consensus that the misc.health category was not the best
choice for a Lyme Disease discussion group for the following reasons:
Many of the respondents were unable to access the misc category at
their sites.  In addition, the consensus felt that the sci.med
category would better serve their desires to have a serious as well as
informative and accessible forum for discussion and would encourage
the participation of the medical and scientific community.  Therefore
we are posting the RFD again under the new name of
sci.med.diseases.lyme.

The first paragraph of the Charter has been amended to include anyone who
has an interest in educating themselves about the symptoms, treatment, and
prevention of Lyme Disease. The second paragraph of the Charter has been
changed to reflect the wishes of the consensus to encourage participation
by the medical and scientific community.  Other changes that have been made
are inessential corrections in wording to clarify the language of the RFD.


This RFD is being posted in accordance with the Guidelines for Newsgroup
Creation.  Its language is based on previously submitted RFDs.  Its
format follows a suggestion by David C. Lawrence, the moderator of
news.announce.newgroups.


RATIONALE:

There is currently no discussion group for the many persons suffering from
Lyme Disease, a devastating illness which has become a problem from North
America to Slovakia or wherever the disease carrying tick thrives. The
symptoms are as varied as the terrain and patients are often left isolated
by these debilitating symptoms in quite rural locations.

Although there are Lyme Disease support groups in various geographic
locations, the severe limitations of the varied symptoms experienced by
patients make it often impossible for them to physically attend these
groups. This proposed newsgroup would give housebound patients a much
needed forum to discuss their problems, symptoms, fears and victories. Lyme
Disease is particularly common among teenagers and young children because
their activities often take them into areas where the tick is found.
Fortunately, many of these young people have access to a computer, usually
through their school. Both young patients and adult sufferers may never
actually meet another Lyme Disease patient face to face, and being able to
communicate via a Lyme Disease newsgroup could be invaluable help in easing
their fears and giving them the support they need.

MAILING LISTS:

There currently exists a Lyme Disease Mailing List, LymeNet, which publishes
an informational newsletter to its 1200 direct subscribers, as well as
being gated to the sci.med newsgroup.  In addition, I am aware that many
people copy the LymeNet Newsletter and redistribute it as per the reprint
agreement.

LymeNet is useful for the dissemination of new information about Lyme
Disease as it is made available and will definitely be useful as a resource
for the proposed discussion group, however it is not able to offer the give
and take that an open discussion group can offer and the publishers of
LymeNet have no plans to make such a discussion group available to all
sites.  We are planning to gateway the LymeNet Mailing List to
sci.med.diseases.lyme.


CHARTER:

The proposed newsgroup is intended for discussion about the many different
aspects of Lyme Disease as experienced by patients, their caregivers,
friends and family members, doctors and other medical professionals, or
anyone affected by or involved with Lyme Disease, as well as those who wish
to learn about its symptoms, latest treatment options and its prevention.

Anyone with an interest in Lyme Disease is free to post, including the
medical and scientific community, as this newsgroup is interested both in
fostering communication between Lyme Disease sufferers from all parts of
the globe, as well as providing an open forum for the exchange of medical
and scientific information which can be useful to all participants.  Above
all, we wish to encourage a supportive and open atmosphere for the free
exchange of opinions and information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness

- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.


PROCEDURE:

If there are no overwhelming objections to the proposed group, there will
be a Call For Votes (CFV) posted to the same groups as this RFD.  The
voting period will be at least 21 days.  If the group passes by receiving a
2/3rds majority of YES votes to all valid YES & NO votes as well as 100
more YES votes than NO votes, it will be created.


DISTRIBUTION:

This RFD is being posted to the following relevant newsgroups:

        news.announce.newgroups, news.groups
        alt.med.fibromyalgia
        alt.support.arthritis, misc.health.arthritis
        sci.med, sci.med.immunology


Subsequent discussion should take place in news.groups only, not in
other above-mentioned groups.  The Followup-To: header is set
accordingly.

Proposed by:    Linda Palund     
Mentor:         Taneli Huuskonen 

From [email protected] Wed Jun 21 16:42:56 1995
Status: RO
Path: uunet!bounce-back
From: [email protected] (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology
Subject: CFV: sci.med.diseases.lyme
Followup-To: poster
Date: 21 Jun 1995 01:20:48 -0400
Organization: Usenet Volunteer Votetakers
Lines: 125
Sender: [email protected]
Approved: [email protected]
Expires: 13 Jul 1995 00:00:00 GMT
Message-ID: 
References: <[email protected]>
Reply-To: [email protected]
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7077 news.groups:154650 sci.med:132685 sci.med.immunology:1864 alt.med.fibromyalgia:25373 alt.support.arthritis:4562 misc.health.arthritis:1930 bionet.microbiology:2566 sci.bio.microbiology:1137

                          FIRST CALL FOR VOTES (of 2)
                   unmoderated group sci.med.diseases.lyme

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease: patient support, research & information.

Votes must be received by 23:59:59 UTC, 12 July 1995.

This vote is being conducted by a neutral third party.  For voting
questions only contact Warren Lavallee .  For
questions about the proposed group contact Linda Palund
.

DISTRIBUTION
This CFV has been cross posted to:

  sci.med, sci.med.immunology, alt.med.fibromyalgia,
  alt.support.arthritis, misc.health.arthritis, bionet.microbiology,
  sci.bio.microbiology

And EMailed to:
	LymeNet 

CHARTER

        The proposed newsgroup, sci.med.diseases.lyme, is intended
for discussion about the many different aspects of Lyme Disease as
experienced by patients, their caregivers, friends and family members,
doctors and other medical professionals, or anyone affected by or
involved with Lyme Disease, as well as those who wish to learn about its
symptoms, latest treatment options and its prevention.

        Anyone with an interest in Lyme Disease is free to post,
including the medical and scientific community, as this newsgroup
is interested both in fostering communication between Lyme Disease
sufferers from all parts of the globe, as well as providing an open
forum for the exchange of medical and scientific information which
can be useful to all participants. Above all, we wish to encourage a
supportive and open atmosphere for the free exchange of opinions and
information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.

LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme

RATIONALE

        There is currently no discussion group for the many persons
suffering from or involved with Lyme Disease. The symptoms of Lyme
Disease are as varied as the terrain in which the disease carrying tick
thrives, and patients are often left isolated by their debilitating
symptoms in quite rural locations. Although there are Lyme Disease
support groups in various geographic locations, the severe limitations
of the symptoms experienced by patients make it often impossible for
them to physically attend these groups. This proposed newsgroup would
give housebound patients a much needed forum to discuss the disease,
as well as giving them the support they need. It will also enable
researchers and doctors from all over the medical and scientific
community who are studying this disease, to communicate via the Lyme
Disease newsgroup and could be invaluable help in the dissemination of
useful information to all persons concerned with Lyme
Disease.


HOW TO VOTE

Send MAIL to:   [email protected]
Just Replying should work if you are not reading this on a mailing list.

Your mail message should contain *one* and only one of the following
statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.
      I vote YES on sci.med.diseases.lyme
      I vote NO on sci.med.diseases.lyme
      I vote ABSTAIN on sci.med.diseases.lyme
      I CANCEL my vote on sci.med.diseases.lyme

Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)

Anything else may be rejected by the automatic vote counting program.  The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.

If you later change your mind you may vote again; only your last valid
vote will count.

Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)

In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.

If you give anyone a copy of the CFV, it must be whole and unmodified.

When in doubt, ask the votetaker.

Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.

The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.

There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.

From [email protected] Tue Jul 11 13:28:22 1995
Status: RO
Path: uunet!in1.uu.net!bounce-back
From: [email protected] (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology
Subject: 2nd CFV: sci.med.diseases.lyme
Followup-To: news.groups
Date: 10 Jul 1995 18:18:46 -0400
Organization: Usenet Volunteer Votetakers
Lines: 125
Sender: [email protected]
Approved: [email protected]
Expires: 13 Jul 1995 00:00:00 GMT
Message-ID: 
Reply-To: [email protected]
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7107 news.groups:158576 sci.med:135050 sci.med.immunology:1963 alt.med.fibromyalgia:27089 alt.support.arthritis:5000 misc.health.arthritis:2126 bionet.microbiology:2694 sci.bio.microbiology:1216

                          LAST CALL FOR VOTES (of 2)
                   unmoderated group sci.med.diseases.lyme

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease: patient support, research & information.

Votes must be received by 23:59:59 UTC, 12 July 1995.

This vote is being conducted by a neutral third party.  For voting
questions only contact Warren Lavallee .  For
questions about the proposed group contact Linda Palund
.

DISTRIBUTION
This CFV has been cross posted to:

  sci.med, sci.med.immunology, alt.med.fibromyalgia,
  alt.support.arthritis, misc.health.arthritis, bionet.microbiology,
  sci.bio.microbiology

And EMailed to:
	LymeNet 

CHARTER

        The proposed newsgroup, sci.med.diseases.lyme, is intended
for discussion about the many different aspects of Lyme Disease as
experienced by patients, their caregivers, friends and family members,
doctors and other medical professionals, or anyone affected by or
involved with Lyme Disease, as well as those who wish to learn about its
symptoms, latest treatment options and its prevention.

        Anyone with an interest in Lyme Disease is free to post,
including the medical and scientific community, as this newsgroup
is interested both in fostering communication between Lyme Disease
sufferers from all parts of the globe, as well as providing an open
forum for the exchange of medical and scientific information which
can be useful to all participants. Above all, we wish to encourage a
supportive and open atmosphere for the free exchange of opinions and
information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.

LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme

RATIONALE

        There is currently no discussion group for the many persons
suffering from or involved with Lyme Disease. The symptoms of Lyme
Disease are as varied as the terrain in which the disease carrying tick
thrives, and patients are often left isolated by their debilitating
symptoms in quite rural locations. Although there are Lyme Disease
support groups in various geographic locations, the severe limitations
of the symptoms experienced by patients make it often impossible for
them to physically attend these groups. This proposed newsgroup would
give housebound patients a much needed forum to discuss the disease,
as well as giving them the support they need. It will also enable
researchers and doctors from all over the medical and scientific
community who are studying this disease, to communicate via the Lyme
Disease newsgroup and could be invaluable help in the dissemination of
useful information to all persons concerned with Lyme
Disease.


HOW TO VOTE

Send MAIL to:   [email protected]
Just Replying should work if you are not reading this on a mailing list.

Your mail message should contain *one* and only one of the following
statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.
      I vote YES on sci.med.diseases.lyme
      I vote NO on sci.med.diseases.lyme
      I vote ABSTAIN on sci.med.diseases.lyme
      I CANCEL my vote on sci.med.diseases.lyme

Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)

Anything else may be rejected by the automatic vote counting program.  The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.

If you later change your mind you may vote again; only your last valid
vote will count.

Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)

In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.

If you give anyone a copy of the CFV, it must be whole and unmodified.

When in doubt, ask the votetaker.

Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.

The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.

There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.

From [email protected] Fri Jul 14 11:19:58 1995
Status: RO
Path: uunet!in1.uu.net!bounce-back
From: [email protected] (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology
Subject: RESULT: sci.med.diseases.lyme passes 131:13
Followup-To: news.groups
Date: 13 Jul 1995 20:26:03 -0400
Organization: Usenet Volunteer Votetakers
Lines: 237
Sender: [email protected]
Approved: [email protected]
Message-ID: 
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7155 news.groups:159392 sci.med:135523 sci.med.immunology:1977 alt.med.fibromyalgia:27383 alt.support.arthritis:5058 misc.health.arthritis:2150 bionet.microbiology:2724 sci.bio.microbiology:1242

                                RESULT
            unmoderated group sci.med.diseases.lyme passes 131:13

There were 131 YES votes and 13 NO votes, for a total of 144 valid votes.
There were 4 abstains and 8 invalid ballots.

For group passage, YES votes must be at least 2/3 of all valid (YES and NO)
votes.   There also must be at least 100 more YES votes than NO votes.

There is a five day discussion period after these results are posted.  If no
serious allegations of voting irregularities are raised, the moderator of
news.announce.newgroups will create the group shortly thereafter.

  sci.med.diseases.lyme passed on Tue Jul 4 15:29:53 1995

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease: patient support, research & information.

This vote was being conducted by a neutral third party. For voting
questions only contact Warren Lavallee . For questions
about the proposed group contact Linda Palund .

CHARTER

        The proposed newsgroup, sci.med.diseases.lyme, is intended
for discussion about the many different aspects of Lyme Disease as
experienced by patients, their caregivers, friends and family members,
doctors and other medical professionals, or anyone affected by or
involved with Lyme Disease, as well as those who wish to learn about its
symptoms, latest treatment options and its prevention.

        Anyone with an interest in Lyme Disease is free to post,
including the medical and scientific community, as this newsgroup
is interested both in fostering communication between Lyme Disease
sufferers from all parts of the globe, as well as providing an open
forum for the exchange of medical and scientific information which
can be useful to all participants. Above all, we wish to encourage a
supportive and open atmosphere for the free exchange of opinions and
information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.

LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme

[This collection of addresses is (C)1995 by Consultix Computer Services.
Permission is strictly NOT given to use this list or any part thereof to
make a mailing list, or for mass-mailings.  Any other use is fine.]
sci.med.diseases.lyme Final Vote Ack

Voted Yes
------------------------------------------------------------------------------
[email protected]                                           Jonathan Adair
[email protected]                                                   Andrew Hall
[email protected]                                                 Aimee Phillpot
[email protected]                                                 Tina M. Wood
[email protected]
[email protected]                                    George Armhold
[email protected]                           Amittai F. Aviram
[email protected]                                           Ed Bailey
[email protected]
[email protected]                                                   beth kaimowitz
[email protected]                                 Douglas P. Shannon
[email protected]                                      Carol J. Botteron
[email protected]
[email protected]                                             Ben Parker
[email protected]                                            Brian Klinkenberg
[email protected]
[email protected]                    Christine Gilmore Eubanks
[email protected]                                                  Chicago
[email protected]                                         Chris Stamper
[email protected]                                        Catherine Nelson
[email protected]                                       Chris Newport
[email protected]                                           Colman M. Jones
[email protected]                                           David Croft
[email protected]
[email protected]                                               Darek Iwanski
[email protected]
[email protected]
[email protected]                                            Dean Jenkins
[email protected]                                                 Dick Manley
[email protected]                                          Doug Murphy
[email protected]                                            Donna Herrell
[email protected]                                                         Ryan
[email protected]                                                            effie
[email protected]                                     Eugene N. Miya
[email protected]                                              Bruce Giese
[email protected]                                      Benedict A. Gomes
[email protected]                                        Pat Gonzales
[email protected]                                                     ZmG
[email protected]                                                 Dick Grady
[email protected]                                                    Kiran Wagle
[email protected]                                               George W. Baltz
[email protected]                                   David Hampson
[email protected]                                                   Hal Blatman
[email protected]
HIRSCHBERG#m#[email protected]     Marvin Hirschberg (216)433-3206
[email protected]                                           Jane Wong
[email protected]                                                Dr Iain G. Old
[email protected]
[email protected]                                        Janet Kowalewski
[email protected]                                             James M. Byers
[email protected]
[email protected]                          Joyce A Knauerhase
[email protected]
[email protected]
[email protected]
[email protected]                                               Mike Lake
[email protected]                                           John Setel O'Donnell
[email protected]                                           Joel Hornstein
[email protected]                                                       Jim Olsen
[email protected]                                                           Jonboy
[email protected]                                        Sudish Joseph
[email protected]                                       Joy Veronneau
[email protected]
[email protected]                                       John R. Sherlock
[email protected]                                               John Lester
[email protected]               Karl-Heinz Kuhn t2150
[email protected]                                          KATHY L. BIRDWELL
[email protected]                                            Ken Descoteaux
[email protected]                               Kimmo Ketolainen +358 40 500 2957
[email protected]                                       Rob Knauerhase
[email protected]                                                 Trisha Benedict
[email protected]                                        Claude Lapointe (ACISD)
[email protected]                                  Martin Schr"oder
[email protected]                                                  Les Thomas
[email protected]                                        Madelaine Davidson
[email protected]                                              Michael A. Chary
[email protected]                                              Marc Dashevsky
[email protected]
[email protected]                                    Mitch Collinsworth
[email protected]                                             Linda Palund
[email protected]                                                 Robert K. Moore
[email protected]                                          Michael Ricci
[email protected]                                     Omer Nirhod
[email protected]                                  Marlene J. Stern
[email protected]                                                     Nigel Allen
[email protected]                                                   Nelia Lyda
[email protected]                           North Haven High School
[email protected]                                          Nick Ingegneri
[email protected]                                           Norman Birkett
[email protected]
[email protected]                                            Philip Decker
[email protected]                                           Peter Rohleder
[email protected]                                      John Pimentel
[email protected]                                            Jim DePietro
[email protected]
[email protected]
[email protected]                                              Rebecca Drayer
[email protected]                                             R.S.LITTLE
[email protected]                         RALPH W. CONNELL - LGSPI
[email protected]                                               Rebecca Otis
[email protected]
[email protected]
[email protected]                                     Ruth Ginzberg
[email protected]                                                          RGyure
[email protected]                                             Richard H. Miller
[email protected]                                  Robert M. Levy
[email protected]
[email protected]                            Roger Marshall
[email protected]                                                    R. S. Camm
[email protected]                                             Robert Smits
[email protected]                                       Jeffrey Rufinus
[email protected]                                           David Revitt
[email protected]                                                      shells
[email protected]                                      timothy shimeall
[email protected]                                        Schuyler W Horton
[email protected]                                                    Gil Singer
[email protected]                                                 Linda W. White
[email protected]                                                     Boudicca
stonesifer#m#[email protected]                      Stonesifer, Phyllis
[email protected]                                                      Steve Roberts
[email protected]                                             s rich
[email protected]                                             Barnet Sherman
[email protected]                                                 Coralie J. Allen
[email protected]                                      Patti Telegan
[email protected]                                            Thomas G. McWilliams
[email protected]
[email protected]                                             T. Singer
[email protected]                                        Tim Pierce
[email protected]                               Abdul W Abdul
[email protected]                                                Ulf Garpmo
[email protected]                                      Ulf Bahrenfuss

Voted No
------------------------------------------------------------------------------
[email protected]                                        Andrew H. Marrinson
[email protected]                                          Anita Kilgour
[email protected]                                                   Balaji
[email protected]                                               Michiel Wijers
[email protected]                                                         Ed Anderson
[email protected]                                                Edward Reid
[email protected]                                                   Emery Lapinski
[email protected]                                                     HiTech
[email protected]                                                  Joel B Levin
[email protected]                                           Kam Shojania, MD
[email protected]                                         Smarasderagd
[email protected]                                                  Dwight Brown
[email protected]                                         Risto Widenius

Abstained
------------------------------------------------------------------------------
[email protected]                              Kenneth P Crouch
[email protected]                  Edward McSweegan
[email protected]                                       Taneli Huuskonen
[email protected]                                          M Mike Taksar KC6ZPS


Votes in error
------------------------------------------------------------------------------
[email protected]                                        Camilla Cracchiolo
   ! No vote statement in message
[email protected]                                                  ewinner
   ! No vote statement in message
[email protected]                                            Ivar van Heijningen
   ! No vote statement in message
[email protected]                                         Johanna Lynch
   ! No vote statement in message
[email protected]                                               Michael J. Reeves
   ! No vote statement in message
[email protected]                                    NEWS News Admin.
   ! Invalid address
[email protected]                                         Robert M. Evans
   ! No vote statement in message
[email protected]                               Vladimir A. Bolibok
   ! Invalid address